These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 28072974)
1. [Clinicopathologic features of mammary analogue secretory carcinoma of salivary glands]. Zhang XP; Ni H; Wang X; Chen H; Shi SS; Yu B; Zhou XJ; Rao Q Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):34-37. PubMed ID: 28072974 [No Abstract] [Full Text] [Related]
2. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin. Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197 [TBL] [Abstract][Full Text] [Related]
3. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion. Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers. Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941 [TBL] [Abstract][Full Text] [Related]
5. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement. Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077 [TBL] [Abstract][Full Text] [Related]
6. The screening and electron microscopy observation of mammary analogue secretory carcinoma in Chinese. Zhong Y; Liu L; Qi B; Song X; Shen L; Li H J Craniomaxillofac Surg; 2018 Jun; 46(6):893-897. PubMed ID: 29752049 [TBL] [Abstract][Full Text] [Related]
7. Extended immunologic and genetic lineage of mammary analogue secretory carcinoma of salivary glands. Ni H; Zhang XP; Wang XT; Xia QY; Lv JH; Wang X; Shi SS; Li R; Zhou XJ; Rao Q Hum Pathol; 2016 Dec; 58():97-104. PubMed ID: 27658560 [TBL] [Abstract][Full Text] [Related]
8. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion. Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470 [TBL] [Abstract][Full Text] [Related]
9. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers. Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394 [TBL] [Abstract][Full Text] [Related]
10. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350 [TBL] [Abstract][Full Text] [Related]
11. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma? Projetti F; Lacroix-Triki M; Serrano E; Vergez S; Barres BH; Meilleroux J; Delisle MB; Uro-Coste E J Oral Pathol Med; 2015 Apr; 44(4):244-51. PubMed ID: 25040635 [TBL] [Abstract][Full Text] [Related]
12. Combined DOG1 and Mammaglobin Immunohistochemistry Is Comparable to ETV6-breakapart Analysis for Differentiating Between Papillary Cystic Variants of Acinic Cell Carcinoma and Mammary Analogue Secretory Carcinoma. Said-Al-Naief N; Carlos R; Vance GH; Miller C; Edwards PC Int J Surg Pathol; 2017 Apr; 25(2):127-140. PubMed ID: 27670353 [TBL] [Abstract][Full Text] [Related]
13. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC). Drilon A; Li G; Dogan S; Gounder M; Shen R; Arcila M; Wang L; Hyman DM; Hechtman J; Wei G; Cam NR; Christiansen J; Luo D; Maneval EC; Bauer T; Patel M; Liu SV; Ou SH; Farago A; Shaw A; Shoemaker RF; Lim J; Hornby Z; Multani P; Ladanyi M; Berger M; Katabi N; Ghossein R; Ho AL Ann Oncol; 2016 May; 27(5):920-6. PubMed ID: 26884591 [TBL] [Abstract][Full Text] [Related]
14. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic study of 11 cases. Din NU; Fatima S; Kayani N Ann Diagn Pathol; 2016 Jun; 22():49-53. PubMed ID: 27180060 [TBL] [Abstract][Full Text] [Related]
16. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study. Stevens TM; Kovalovsky AO; Velosa C; Shi Q; Dai Q; Owen RP; Bell WC; Wei S; Althof PA; Sanmann JN; Sweeny L; Carroll WR; Siegal GP; Bullock MJ; Brandwein-Gensler M Mod Pathol; 2015 Aug; 28(8):1084-100. PubMed ID: 26089091 [TBL] [Abstract][Full Text] [Related]
17. The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases. Griffith CC; Stelow EB; Saqi A; Khalbuss WE; Schneider F; Chiosea SI; Seethala RR Cancer Cytopathol; 2013 May; 121(5):234-41. PubMed ID: 23225548 [TBL] [Abstract][Full Text] [Related]
18. Mammary Analogue Secretory Carcinoma of the Thyroid Mimicking Locally Advanced Papillary Thyroid Carcinoma: A Rare Case Report. Liao H; Khan A; Miron PM; Cornejo KM Int J Surg Pathol; 2018 Aug; 26(5):459-463. PubMed ID: 29228842 [TBL] [Abstract][Full Text] [Related]
19. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558 [TBL] [Abstract][Full Text] [Related]
20. Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity. Rooper LM; Karantanos T; Ning Y; Bishop JA; Gordon SW; Kang H Am J Surg Pathol; 2018 Aug; 42(8):1121-1126. PubMed ID: 29683815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]